E van Strijen
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- H. Mattie (11 shared papers)Peter H. Nibbering (3 shared papers)Herman Mattie (2 shared papers)C. van Gulpen (2 shared papers)Jaap T. van Dissel (2 shared papers)Nicolle H. R. Litjens (2 shared papers)Louise A. Duits (1 shared paper)Joost B. Vos (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)British Journal of Clinical Pharmacology (4 papers)Nature Communications (1 paper)Journal of Clinical Microbiology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- NetherlandsSlovenia
In The Last Decade
E van Strijen
17 papers receiving 556 citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 121
- Microbiology 73
- Pharmacology 122
- Endocrinology 38
- Immunology 128
Countries citing papers authored by E van Strijen
This map shows the geographic impact of E van Strijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E van Strijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E van Strijen more than expected).
Fields of papers citing papers by E van Strijen
This network shows the impact of papers produced by E van Strijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E van Strijen. The network helps show where E van Strijen may publish in the future.
Co-authors
The 25 scholars most cited alongside E van Strijen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 120 | |
| 2 | 2003 | 103 | |
| 3 | 2009 | 60 | |
| 4 | 2004 | 55 | |
| 5 | 2018 | 45 | |
| 6 | 1990 | 31 | |
| 7 | 1994 | 29 | |
| 8 | 1983 | 23 | |
| 9 | 1990 | 23 | |
| 10 | 1997 | 20 | |
| 11 | 1992 | 18 | |
| 12 | 1992 | 16 | |
| 13 | 1993 | 15 | |
| 14 | 1999 | 11 | |
| 15 | 1991 | 6 | |
| 16 | 1992 | 6 | |
| 17 | 1991 | 3 |
About E van Strijen
E van Strijen is a scholar working on Pharmacology, Molecular Medicine, Oncology, Infectious Diseases and Surgery, having authored 17 papers that have together received 584 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers), Drug Transport and Resistance Mechanisms (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Neutropenia and Cancer Infections (1 paper), Analytical Chemistry and Sensors (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Molecular Medicine (121 citations), Microbiology (73 citations), Pharmacology (122 citations), Endocrinology (38 citations) and Immunology (128 citations). E van Strijen has collaborated with scholars based in Netherlands and Slovenia. Frequent co-authors include H. Mattie, Peter H. Nibbering, Herman Mattie, C. van Gulpen, Jaap T. van Dissel, Nicolle H. R. Litjens, Louise A. Duits, Joost B. Vos, Pieter S. Hiemstra and M L van Ogtrop. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology, Nature Communications, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.